HLA ‐ DR / DQ molecular mismatch: A prognostic biomarker for primary alloimmunity-Reference-Cited by-同舟云学术

HLA ‐ DR / DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

Published:2018-12-15 Issue:6 Volume:19 Page:1708-1719
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Wiebe Chris¹²,Kosmoliaptsis Vasilis³⁴⁵,Pochinco Denise²,Gibson Ian W.²⁶,Ho Julie¹⁷,Birk Patricia E.⁸,Goldberg Aviva⁸,Karpinski Martin¹,Shaw Jamie¹,Rush David N.¹,Nickerson Peter W.¹²⁷

Affiliation:

1. Department of Medicine University of Manitoba Winnipeg ManitobaCanada

2. Shared Health Services Manitoba Winnipeg ManitobaCanada

3. Department of Surgery University of Cambridge Addenbrooke's Hospital CambridgeUK

4. NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge CambridgeUK

5. The NIHR Cambridge Biomedical Research Centre CambridgeUK

6. Department of Pathology University of Manitoba Winnipeg ManitobaCanada

7. Department of Immunology University of Manitoba Winnipeg ManitobaCanada

8. Department of Pediatrics and Child Health University of Manitoba Winnipeg Manitoba Canada

Funder

Canadian Institutes of Health Research

National Institute for Health Research

Research Manitoba

Evelyn Trust

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15177

Reference30 articles.

1. Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients

2. Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice

3. Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients

4. Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients

5. Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interchain disulfide engineering enables the efficient production of functional HLA-DQ-Fc fusion proteins;Journal of Biological Chemistry;2024-09

2. Chronic Rejection After Kidney Transplantation;Transplantation;2024-08-28

3. HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens;Frontiers in Genetics;2024-08-28

4. Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development;Antibodies;2024-07-24

5. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23